BP's profit fell more than expected as weak refining margins dragged on its results but the British energy major still launched a $1.75 billion quarterly buyback. Elliott Builds Over $2.5 Billion ...

The British oil and gas giant's Chief Executive Murray Auchincloss said the company would continue to reshape its portfolio and has made strong progress in cutting costs. BP now plans to change its ...

The Italian bank on Tuesday said it expects this year's net profit to be broadly in line with 2024's result of 9.31 billion euros ($9.60 billion). UniCredit's net profit metric is adjusted for ...

BP's profit fell more than expected as weak refining margins dragged on its results but the British energy major still launched a $1.75 billion quarterly buyback.

DSM-Firmenich is selling its 50% stake in the Feed Enzymes Alliance to its partner Novonesis for 1.5 billion euros ($1.55 billion). The Dutch nutrition, health and bioscience company said Tuesday that ...

The company's star label Gucci posted quarterly sales of 1.92 billion euros, down 24% on year. "We are confident that we have driven Kering to a point of stabilization, from which we will gradually ...

Hanwha Aerospace's shares rallied after posting strong fourth-quarter earnings and increasing its stake in its promising ship-making sibling. The South Korean defense company's stock jumped 21% ...

Macron aims to dedicate a gigawatt of nuclear power to create one of the world's largest AI-computing facilities.

Novartis said it has agreed to acquire U.S. privately held, clinical-stage biopharmaceutical company Anthos Therapeutics for up to $3.08 billion to boost its cardiovascular pipeline.

The Italian bank on Tuesday said it expects net profit to be broadly in line with 2024's result of 9.31 billion euros ($9.60 billion). UniCredit's net profit metric is adjusted for previous year's tax ...

Germany's Merck KGaA said it is in advanced talks for a potential acquisition of SpringWorks Therapeutics, a U.S. biopharmaceutical company that specializes in rare diseases and cancer.

With inflation sticky, market participants have been steadily paring back their expectations for an interest rate cut at the ...